Sandra Williams
Medical · Rochester, NYNPI 1558397372
Payments from drug & device makers
Across 224 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$637
- Novo Nordisk$572
- Lilly USA, LLC$332
- Bayer$309
- Amgen$241
- Baxter Healthcare$208
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,92495%
- Other$2085%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $637 |
| Novo Nordisk | 45 | $572 |
| Lilly USA, LLC | 20 | $332 |
| Bayer | 11 | $309 |
| Amgen | 13 | $241 |
| Baxter Healthcare | 1 | $208 |
| GSK | 4 | $180 |
| AstraZeneca | 9 | $176 |
| Idorsia Pharmaceuticals US Inc | 5 | $151 |
| Exact Sciences | 7 | $138 |
| Novartis | 6 | $128 |
| Phathom Pharmaceuticals, Inc. | 5 | $106 |
| Boehringer Ingelheim | 5 | $92 |
| Merck | 5 | $81 |
| Insulet Corporation | 4 | $77 |
| Johnson & Johnson | 4 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| E.r. Squibb & Sons, L.L.C. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Currax Pharmaceuticals LLC | 3 | $49 |
| Ironwood Pharmaceuticals, Inc | 2 | $48 |
| Dexcom, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Abbott | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $23 |
| Boston Scientific | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
| Tolmar, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,132 in reported general payments places this provider in the 85th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $56,302 |
| TrulicityDulaglutide | 34 | $55,224 |
| JardianceEmpagliflozin | 27 | $45,011 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $41,576 |
| OzempicSemaglutide | 25 | $35,249 |
| ProliaDenosumab | 13 | $21,170 |
| MyrbetriqMirabegron | 15 | $17,257 |
| Atorvastatin Calcium | 443 | $8,038 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $4,905 |
| Sumatriptan Succinate | 42 | $4,765 |
| Bupropion XlBupropion Hcl | 79 | $3,931 |
| Rosuvastatin Calcium | 173 | $3,909 |
| Gabapentin | 159 | $2,788 |
| Duloxetine Hcl | 80 | $2,615 |
| Perphenazine | 12 | $2,385 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $332 | $55,22434 claims |
| Boehringer IngelheimJardiance | $92 | $45,01127 claims |
| GSKTrelegy Ellipta | $180 | $41,57653 claims |
| Novo NordiskOzempic | $572 | $35,24925 claims |
| AmgenProlia | $241 | $21,17013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,395 medical providers in New York.
Other medical in Rochester
- Gina FriesRochester$106K
- Brandon YehlRochester$24K
- Michael BrownRochester$16K
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Ilse StraussSmithtown$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.